Divis Laboratories Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 2,407 | 2,142 | 2,338 |
| Operating Expense | 1,573 | 1,442 | 1,542 |
| Net Profit | 518 | 430 | 531 |
| Net Profit Margin | 21.52 | 20.07 | 22.71 |
| Earning Per Share | 19.51 | 16.18 | 19.99 |
| EBIDTA | 835 | 705 | 786 |
| Effective Tax Rate | 26.14 | 25.43 | 19.97 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 2407.00 |
| Operating Expense | 1573.00 |
| Net Profit | 518.00 |
| Net Profit Margin | 21.52 |
| Earning Per Share | 19.51 |
| EBIDTA | 835.00 |
| Effective Tax Rate | 26.14 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 7,665 | 7,625 | 8,879.82 |
| Operating Expenses Annual | 5,491 | 5,277 | 5,003.36 |
| Operating Profit Annual | 2,511 | 2,697 | 3,987.72 |
| Interest Annual | 3 | 1 | 0.65 |
| Depreciation | 373 | 338 | 307.37 |
| Net Profit Annual | 1,576 | 1,808 | 2,948.54 |
| Tax Annual | 556 | 546 | 727.98 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 7,665 |
| Operating Expenses Annual | 5,491 |
| Operating Profit Annual | 2,511 |
| Interest Annual | 3 |
| Depreciation | 373 |
| Net Profit Annual | 1,576 |
| Tax Annual | 556 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 144 | 1,200 | 2,016.30 |
| Cash Flow from Operations | 1,266 | 2,447 | 1,910.16 |
| Cash Flow from Investing | -268 | -2,707 | -2,195.40 |
| Cash Flow from Financing | -798 | -796 | -531.50 |
| Cash Flow at the End | 344 | 144 | 1,199.56 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 144 |
| Cash Flow from Operations | 1,266 |
| Cash Flow from Investing | -268 |
| Cash Flow from Financing | -798 |
| Cash Flow at the End | 344 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 32.77 | 35.38 | 44.92 |
| PBIT Margin (%) | 27.87 | 30.90 | 41.42 |
| PBT Margin (%) | 20.90 | 15.45 | 17.48 |
| Net PROFIT Margin (%) | 20.56 | 23.71 | 33.20 |
| Return On Networth / Equity (%) | 12.04 | 14.82 | 28.13 |
| Return On Networth /Employed (%) | 16.27 | 19.27 | 35.01 |
| Return On Assets (%) | 11.93 | 14.70 | 28.22 |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 0.58 | 0.62 | 0.85 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 32.77 |
| PBIT Margin (%) | 27.87 |
| PBT Margin (%) | 20.90 |
| Net PROFIT Margin (%) | 20.56 |
| Return On Networth / Equity (%) | 12.04 |
| Return On Networth /Employed (%) | 16.27 |
| Return On Assets (%) | 11.93 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.58 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 4,737 | 4,719 | 4,320.97 |
| Total Current Assets Annual | 9,572 | 9,236 | 8,295.96 |
| Non Current Assets Annual | 5,790 | 5,116 | 5,011.90 |
| Total Shareholders Funds Annual | 13,484 | 12,705 | 11,691.35 |
| Total Assets Annual | 15,362 | 14,352 | 13,307.86 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 4,737 |
| Total Current Assets Annual | 9,572 |
| Non Current Assets Annual | 5,790 |
| Total Shareholders Funds Annual | 13,484 |
| Total Assets Annual | 15,362 |
EPS (INR)
Expected
19.25
Reported
19.20
Surprise
-0.26%
Jun 2024
EPS beaten by -0.26%
Mar 2024
EPS beaten by -0.18%
Dec 2023
EPS beaten by -0.25%
